E-learning pharmacovigilance course from UMC well received
- PDF / 169,892 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 75 Downloads / 151 Views
1
E-learning pharmacovigilance course from UMC well received An e-learning pharmacovigilance (PV) course developed by the WHO’s Uppsala Monitoring Centre (UMC) has been well received throughout the world, according to findings of a study published in Drug Safety. Acceptance of the UMC’s e-learning course, a microlearning approach with small learning modules targeting specific learning objectives, was investigated by assessing usage data and results of user surveys on modules 1–4 (signal detection and causality; launched in 2017) and module 5 (statistical reasoning and algorithms; launched in 2018) in 137 countries. The survey on modules 1–4 was completed by 40.7% of the 2067 people who enrolled in it, and the survey on module 5 was completed by 65.9% of the 1685 people who enrolled in it. Most participants were from the pharmaceutical industry (36.6%), national PV centres (22.6%) or academia (16.3%). Satisfaction ratings were excellent or good in over 90% of learners. Most particpants expressed satisfaction with the learning platform, course content and the duration of lessons, and most believed they would be able to apply the knowledge gained. Over 99% of particpants would recommend the e-learning course to others, and would study future modules. Suggested enhancements included an interactive forum, more practical examples, and practice exercises. "This UMC e-learning course in pharmacovigilance based on microlearning was well received across all the aspects evaluated, with a global coverage among relevant professional disciplines, including the primary target group, national PV centre staff," said the authors. Hegerius A, et al. E-Learning in Pharmacovigilance: An Evaluation of Microlearning-Based Modules Developed by Uppsala Monitoring Centre. Drug Safety : 13 Aug 2020. Available from: URL: https://doi.org/10.1007/s40264-020-00981-w 803497972
0114-9954/20/1818-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 22 Aug 2020 No. 1818
Data Loading...
